Search research articles
Contact Us
Filters
Showing results (1-10 of 32) with videos related to
Page
of 4
Sort By:
Annals of Internal Medicine
|
November 2, 2016
Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease
Robert Haussmann, Markus Donix
International Clinical Psychopharmacology
|
January 31, 2023
Pharmacologic treatment of depression in Alzheimer's disease
Robert Haussmann, Markus Donix
Journal of Attention Disorders
|
April 30, 2011
Perinatal Pitocin as an early ADHD biomarker: neurodevelopmental risk?
Lisa Kurth, Robert Haussmann
International Journal of Emergency Mental Health
|
July 31, 2013
The effects of mortality salience and conceptual focus in CISM providers: implications for mental health response to mass fatality disasters
Hope E Morrow, Robert Haussmann
Pharmacopsychiatry
|
May 19, 2017
Robert Haussmann, Maria Buthut, Markus Donix
Asian Journal of Psychiatry
|
October 1, 2019
Gender differences in the perception of cognitive decline
Robert Haussmann, Cathrin Sauer, Anja Birnbaum, et al.
Der Nervenarzt
|
March 29, 2021
[Consequences of the COVID-19 pandemic for people with schizophrenia, dementia and substance use disorders]
Kristina Adorjan, Robert Haussmann, Katrin Rauen, et al.
Der Nervenarzt
|
July 22, 2022
[Chronobiological interventions for prevention and treatment of delirium in critically ill patients]
Sebastian Schmidt, Laura Hancke, Robert Haussmann, et al.
Journal of Healthcare Risk Management : the Journal of the American Society for Healthcare Risk Management
|
August 24, 2018
Health care risk managers' consensus on the management of inappropriate behaviors among hospital staff
Sahar Ebrahim Zadeh, Robert Haussmann, Craig D Barton
Neurology
|
April 7, 2022
Bing-Neel Syndrome Mimicking Behavioral Variant Frontotemporal Dementia
Markus Donix, Robert Haussmann, Moritz D Brandt, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 32) with videos related to
Sort By:
Page
of 4
Annals of Internal Medicine
|
November 2, 2016
Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease
Robert Haussmann, Markus Donix
International Clinical Psychopharmacology
|
January 31, 2023
Pharmacologic treatment of depression in Alzheimer's disease
Robert Haussmann, Markus Donix
Journal of Attention Disorders
|
April 30, 2011
Perinatal Pitocin as an early ADHD biomarker: neurodevelopmental risk?
Lisa Kurth, Robert Haussmann
International Journal of Emergency Mental Health
|
July 31, 2013
The effects of mortality salience and conceptual focus in CISM providers: implications for mental health response to mass fatality disasters
Hope E Morrow, Robert Haussmann
Pharmacopsychiatry
|
May 19, 2017
Robert Haussmann, Maria Buthut, Markus Donix
Asian Journal of Psychiatry
|
October 1, 2019
Gender differences in the perception of cognitive decline
Robert Haussmann, Cathrin Sauer, Anja Birnbaum, et al.
Der Nervenarzt
|
March 29, 2021
[Consequences of the COVID-19 pandemic for people with schizophrenia, dementia and substance use disorders]
Kristina Adorjan, Robert Haussmann, Katrin Rauen, et al.
Der Nervenarzt
|
July 22, 2022
[Chronobiological interventions for prevention and treatment of delirium in critically ill patients]
Sebastian Schmidt, Laura Hancke, Robert Haussmann, et al.
Journal of Healthcare Risk Management : the Journal of the American Society for Healthcare Risk Management
|
August 24, 2018
Health care risk managers' consensus on the management of inappropriate behaviors among hospital staff
Sahar Ebrahim Zadeh, Robert Haussmann, Craig D Barton
Neurology
|
April 7, 2022
Bing-Neel Syndrome Mimicking Behavioral Variant Frontotemporal Dementia
Markus Donix, Robert Haussmann, Moritz D Brandt, et al.
Page
of 4